Skip to main content

Table 1 Baseline clinical characteristics

From: The value of diastolic function parameters in the prediction of left atrial appendage thrombus in patients with nonvalvular atrial fibrillation

  LAAT (+) LAAT (−) P value
N = 19 N = 278
Age (years), mean ± SD 66 ± 13 62 ± 14 0.37
Age ≥ 75 years, n (%) 5 (26%) 55 (20%) 0.49
Male gender, n (%) 14 (74%) 176 (63%) 0.36
Hypertension, n (%) 16 (84%) 177 (64%) 0.07
Diabetes mellitus, n (%) 8 (42%) 73 (26%) 0.13
Congestive heart failure, n (%) 15 (79%) 132 (47%) 0.01
History of stroke or TIA, n (%) 2 (11%) 27 (10%) 0.91
Aspirin, n (%) 9 (47%) 122 (44%) 0.79
Clopidogrel, n (%) 2 (11%) 16 (6%) 0.41
Antiplatelet, n (%) 10 (53%) 126 (46%) 0.56
Warfarin, n (%) 15 (79%) 148 (53%) 0.03
CHADS 2 score, mean ± SD 2.6 ± 1.2 1.9 ± 1.3 0.009*
CHA 2 DS 2 -VASc Score, mean ± SD 3.5 ± 1.7 2.8 ± 1.8 0.08*
CHADS 2 Score ≥ 2, n (%) 17 (89%) 158 (57%) 0.005
Duration since first AF episode (days), median (interquartile range) 691.5 (90–1163) 162 (4–1249) 0.28*
AF type, n (%)    
  • Paroxysmal 8 (42%) 153 (55%) 0.27
  • Persistent 4 (21%) 58 (21%) 0.98
  • Permanent 7 (37%) 67 (24%) 0.21
Creatinine (mg/dL), mean ± SD 1.6 ± 0.7 1.4 ± 1.0 0.047*
  1. LAAT: left atrial appendage thrombus; SD: standard deviation; TIA: transient ischemic attack; AF: atrial fibrillation. * Mann–Whitney U test.